Preserving the Practice of Urology in California Since 1986
Frontlines
CMA President Peter N. Bretan, Jr., M.D., statement on George Floyd death
California Medical Association (CMA) President Peter N. Bretan, Jr., M.D., released the following statement in response to the death of…
Read MoreMessage from the President – Matt Cooperberg, MD
Greetings to all California urologists: The COVID-19 pandemic is easily on track to effect the greatest social upheaval the world…
Read MoreSpecial Bulletin – Telehealth Alert
Dear Members and Colleagues, The CUA wishes to share a recent Telehealth Alert from Mark Painter at PRS as well…
Read MoreCMA urges Congress to protect the viability of physician practices during COVID-19 crisis
The California Medical Association, in conjunction with other state medical associations — representing hundreds of thousands of physicians who are…
Read MoreHistoric! CUA President, Peter Bretan, Jr. installed as CMA President
CONGRATULATIONS PETER ON YOUR TERM AS CMA PRESIDENT! CUA President, Dr. Peter Bretan, took the podium as newly installed CMA…
Read More
RSVP for “Silent Killer” Documentary – Oct. 17
The CUA will be taking part in a panel discussion that will follow the ZERO Prostate “Silent Killer” documentary in…
Read MoreACR 111, Kiley – proclaims the month of September 2019 as Prostate Cancer Awareness Month in California
Assembly Concurrent Resolution No. 111 CHAPTER 135 Relative to Prostate Cancer Awareness Month. [ Filed with Secretary of…
Read MoreResident doctors say UC Davis Health has agreed to bargain with their union
Article from the Sacramento Bee, May 1 By Alyssa Hodenfield | Cathie Anderson UC Davis Health has agreed to negotiate…
Read MoreGood news for coalition opposing SB201 (Intersex)
Faced with a broad coalition of pediatric and urological societies, plus powerful patient testimony and CUA/CMA opposition, the committee hearing…
Read MoreHow to Avoid HIPAA Violations on Social Media
How to Avoid HIPAA Violations on Social Media HIPAA, or the Health Insurance Portability and Accountability Act, was passed in…
Read MoreCUA Annual Meeting 2022
@ WSAUA Meeting, Hyatt Kauai, October 30, 2022
- All urologists & health pros invited
- Date & Time tbd
CMA 48th Annual Legislative Advocacy Day – Tuesday, April 19, 2022 in Sacramento
click here for info
Ask your lawmakers to support access to cost free prostate cancer screenings for men in California. Urge them to support AB 632 today.
This bill will save lives and help lessen healthcare disparities!
https://conta.cc/3KZCgKK
All Urologists and Staff Invited!
Special 45 minute Webinar
OPTIMIZING MEDICARE FOR UROLOGISTS
Thursday, January 12 at 5:15pm
For Urology Practice Managers and Urologists
https://myemail.constantcontact.com/Webinar-Invitation---Jan-12-RSVP-Now.html?soid=1133268891991&aid=w5V7sYHghBY
@Calurology
Insurers have limited access to #biomarker testing for thousands of Californians living with #cancer. We urge @GavinNewsom to sign #SB912, which would broaden coverage of comprehensive biomarker testing. @tam_tweets @JimDeBoo
Lower-income and vulnerable CA communities have less access to #biomarker testing. @GovernorNewsom, signing #SB912 is a matter of health equity. @tam_tweets @JimDeBoo
Greater transparency in the #340B Drug Pricing Program can help ensure it benefits California's uninsured and underinsured patients most, rather than out of state contract pharmacies.
#PeertoPeer review and approval of #steptherapy and #priorauthorization is crucial for the health of patients! #AB1880 #CALeg
Scores of urologists planning legislative meetings in Congress today on behalf of practices across the nation... "Don't raise your voice, improve your argument".. Desmond Tutu #auasummit22 @AmeriUrological
4When programs like the #340B drug discount program do not function as intended or are abused, CA’s underserved and vulnerable patient communities can bear a disproportionate burden.
The #340B drug program is now the country's second largest federal prescription drug program, behind only #Medicare Part D. Despite the size of the program, there is little transparency to ensure that the CA patients who need it are benefiting.